Oslo Cancer Cluster Incubator

Oslo Cancer Cluster Incubator serves as a catalyst for innovation in cancer diagnostics and therapeutic development through its comprehensive ecosystem. Strategically positioned within the Oslo Cancer Cluster Innovation Park, the facility benefits from its proximity to the Institute of Cancer Research, Oslo University Hospital (Radiumhospitalet), and Ullern Upper Secondary School. This unique integration creates a collaborative environment where scientific research, clinical expertise, and educational opportunities converge to advance oncology innovations. Established in 2015 at Montebello, the Incubator operates with backing from the Norwegian government to foster healthcare enterprise development throughout the country.

The Incubator encompasses 5,000 square meters of modern infrastructure, housing a diverse community of startups, global pharmaceutical companies, consultants, service providers, investors, and research institutions. Its state-of-the-art facilities include specialized laboratories, office spaces, and various meeting venues including auditoriums available upon request. This physical environment is designed to nurture cross-disciplinary collaboration and accelerate the translation of scientific discoveries into clinical applications. The strategic co-location of different stakeholders creates natural opportunities for knowledge exchange and partnership formation within the cancer research and development ecosystem.

A dedicated professional team provides comprehensive support to Incubator members, offering access to cutting-edge research facilities, specialized business development services, and connections to an extensive international network of investors and industry leaders. This support system is particularly valuable for early-stage companies navigating the complex pathway from scientific discovery to market-ready products. The Incubator's approach addresses the full spectrum of challenges faced by biotech startups, from technical validation and regulatory compliance to funding acquisition and commercial strategy development. This holistic support model significantly enhances the success potential of member companies.

Beyond supporting established researchers and companies, the Incubator creates an inspirational campus environment for students with aspirations in life sciences. This educational component represents a forward-thinking approach to talent development in the biomedical sector, exposing young minds to real-world applications of scientific concepts. The Incubator's ownership structure, comprising Oslo Cancer Cluster, Siva, Inven2, and Radforsk, brings together expertise from research, innovation, technology transfer, and investment sectors. This diverse stakeholder base ensures the Incubator maintains a balanced focus on scientific excellence, commercial viability, and societal impact in its mission to advance cancer care solutions.